Electromed, Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. On September 9, 2025, we announced the approval of a stock repurchase authorization. Under this authorization, the Company may repurchase up to $10.0 million of outstanding shares of our common stock. The shares of our common stock may be repurchased under authorization on the open market or in privately negotiated transactions subject to applicable securities laws and regulations. The current repurchase authorization does not expire and as of December 31, 2025, a total of 146,441 shares have been repurchased under the authorization with an average cost of $25.72 per share. The approximate dollar value of shares that may yet be purchased under the plan as of December 31, 2025, was approximately $6,235,000. The following table sets forth information concerning all repurchases of shares of our common stock, including shares reacquired to satisfy tax withholding obligations upon vesting of restricted stock awards, for the three months ended December 31, 2025: Total Number of Approximate Dollar Shares Purchased Value of Shares that as Part of Publicly May Yet be Purchased Total Number of Average Price Announced Plans Under the Plans Period Shares Purchased Paid per Share or Programs or Programs October 1 – October 31, 2025 13,625 $ 24.01 13,625 $ 8,670,000 November 1 – November 30, 2025 48,784 $ 25.57 48,784 $ 7,423,000 December 1 – December 31, 2025 (a) 43,391 $ 27.51 43,184 $ 6,235,000 Total 105,800 105,593 (a) Includes 207 shares forfeited to the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock awards that were outstanding under the 2023 Equity Incentive Plan. The average price paid per share reflects the closing price of our common stock on the date of vesting. Item 3. Defaults Upon Senior Securities. None. Item 4. Mine Safety Disclosures. None.